Work

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(26)00160-9

Authors: Stanley H Hsia, Harold E Bays, Liana K Billings, Ann Marie K Weideman, Kieren J Mather, Tamer Coskun, Axel Haupt, Melissa K Thomas, Lai San Tham, Boris Calderon, Wei Ni, Olimpia Ferreira Galvao De Araujo

Institutions: Velocity Clinical Research (United States), Louisville Metabolic and Atherosclerosis Research Center, Endeavor Health, University of Chicago, Eli Lilly (United States)

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W7203881510

FWCI: 2.537

Cites: 29

Cited by: 1

Related to: 10